Woodline Partners LP Heron Therapeutics, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $514,561 - $1.07 Million	-228,694 Reduced 28.66%	569,212 $1.42 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $53,880 - $108,774	-20,256 Reduced 2.48%	797,906 $3.37 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $572,716 - $1.57 Million	249,007 Added 43.75%	818,162 $2.28 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $52,578 - $112,878	11,356 Added 2.04%	569,155 $3.26 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $4.66 Million - $7.03 Million	557,799 New	557,799 $5.09 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.